Related references
Note: Only part of the references are listed.Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications
W. H. Herman et al.
DIABETIC MEDICINE (2012)
Insulin resistance in the nervous system
Bhumsoo Kim et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
The identification of gene expression profiles associated with progression of human diabetic neuropathy
Junguk Hur et al.
BRAIN (2011)
Profibrinolytic, Antithrombotic, and Antiinflammatory Effects of an Insulin-Sensitizing Strategy in Patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
Burton E. Sobel et al.
CIRCULATION (2011)
Association of Metformin, Elevated Homocysteine, and Methylmalonic Acid Levels and Clinically Worsened Diabetic Peripheral Neuropathy
Daryl J. Wile et al.
DIABETES CARE (2010)
Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study
James W. Albers et al.
DIABETES CARE (2010)
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
Solomon Tesfaye et al.
DIABETES CARE (2010)
Beyond Hemoglobin A1c-Need for Additional Markers of Risk for Diabetic Microvascular Complications
Irl B. Hirsch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
p38 mediates mechanical allodynia in a mouse model of type 2 diabetes
Hsinlin T. Cheng et al.
MOLECULAR PAIN (2010)
Microvascular Reactivity and Inflammatory Cytokines in Painful and Painless Peripheral Diabetic Neuropathy
John Doupis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort
Rodica Pop-Busui et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2009)
A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Pro-inflammatory mechanisms in diabetic neuropathy: Focus on the nuclear factor kappa B pathway
Norman E. Cameron et al.
CURRENT DRUG TARGETS (2008)
Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice
Timothy D. Wiggin et al.
ENDOCRINOLOGY (2008)
Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons
Mohamad-Yehia El-Mir et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2008)
The PPARγ ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice
Jinah Hwang et al.
VASCULAR PHARMACOLOGY (2007)
The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells
Sangeeta Ghosh et al.
MOLECULAR PHARMACOLOGY (2007)
Enhanced inflammatory response via activation of NF-κB in acute experimental diabetic neuropathy subjected to ischemia-reperfusion injury
Yanping Wang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial
Maria Mori Brooks et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Metformin inhibits proinflammatory responses and nuclear factor-κB in human vascular wall cells
K Isoda et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Anti-inflammatory effects of short-term pioglitazone therapy in men with advanced diabetic nephropathy
R Agarwal
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Neuropathy among the Diabetes Control and Complications Trial cohort 8 years after trial completion
CL Martin et al.
DIABETES CARE (2006)
Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes
FMAC Martens et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
The global burden of diabetic foot disease
AJM Boulton et al.
LANCET (2005)
Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process
D Detaille et al.
DIABETES (2005)
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
HY Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus
SM Haffner et al.
CIRCULATION (2002)
Cellular mechanisms in the development and progression of diabetic nephropathy: Activation of the DAG-PKC-ERK pathway
M Haneda et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
Share Paper
